Transform Your Life With Spravato® Treatment for Depression
At Renue Wellness, we help patients find rapid relief from treatment-resistant depression through Spravato® (esketamine) — an FDA-approved nasal spray that works differently than traditional antidepressants.
What is Spravato®?
Spravato® is the brand name for esketamine, a prescription nasal spray developed by Janssen Pharmaceuticals and FDA-approved in 2019 for adults with treatment-resistant depression (TRD), and for major depressive disorder (MDD) with suicidal thoughts or actions.
Unlike standard antidepressants, which can take weeks to work, Spravato® acts on the brain’s glutamate system — targeting NMDA receptors involved in mood regulation, rather than the serotonin pathways most oral antidepressants rely on. This different mechanism is why many patients notice meaningful symptom relief within days, not weeks.
Prescription nasal spray
Spravato® is the brand name for esketamine, administered as a prescription nasal spray.
FDA-approved
FDA-approved in 2019 for adults with treatment-resistant depression and certain cases of major depressive disorder.
Meaningful symptom relief
This different mechanism is why many patients notice meaningful symptom relief within days, not weeks.
How Spravato® works
When administered under medical supervision, Spravato® enters the bloodstream through the nasal passages and stimulates NMDA (N-methyl-D-aspartate) receptors in the brain. This activation encourages neural growth and connectivity, helping reverse the patterns of negative thought and emotional stagnation commonly seen in depression.
Patients typically begin to notice improvement after a few sessions, with a full treatment plan tailored to individual needs and response.
Benefits of Spravato® treatment at Renue Wellness
FDA-Approved for Depression
Backed by clinical research and long-term safety data.
Insurance-Covered
Most major insurance providers cover Spravato®, making it an affordable option for many patients.
Fast-Acting Relief
Many patients report feeling better within 24–48 hours of initial treatment.
One Team, Every Option
If Spravato® isn't the right fit, or your response plateaus, our clinical team also offers TMS and IV ketamine therapy — most Spravato providers offer this treatment alone.
Medically Supervised
Every session is closely monitored by our experienced clinical team.
What to expect during Spravato® treatment
Consultation
Review your history, current symptoms, and previous treatments.
Personalized Recommendation
Your provider recommends the treatment option — or combination of options — best suited to your diagnosis and goals.
Dedicated Treatment Plan
Detailed, session-by-session information for each treatment is available on its dedicated page.
Why choose Renue for Spravato®
One team, every option
Spravato®, TMS, and IV ketamine therapy are all available under the same clinical team — most Spravato providers we found in every market we researched offer Spravato® alone.
Experienced Clinical Team
Experienced clinical team specializing in ketamine and esketamine therapies, with board-certified physicians overseeing every treatment plan.
Safety, Comfort & Individualized Care
Focused on patient safety, comfort, and individualized care at every location.
Multiple Convenient Locations
Multiple convenient locations across New York, New Jersey, and Florida.
Multiple clinics, one standard of care.
Who Is a candidate for Spravato®?
You may be a candidate for Spravato® treatment if you:
Have major depressive disorder (MDD) or treatment-resistant depression (TRD)
Have tried two or more antidepressants without adequate relief
Continue to experience symptoms like persistent sadness, hopelessness, or lack of motivation despite therapy or medication
Have been diagnosed with treatment-resistant depression or MDD with suicidal thoughts or actions
Important Considerations
Spravato® is not recommended for individuals with certain conditions, such as aneurysmal vascular disease or a history of hypersensitivity to esketamine. Our providers conduct a thorough medical history review before approving treatment.
Does insurance cover Spravato®?
Yes — Spravato® is covered by many major insurance providers, including commercial plans and Medicare. Because Spravato® is FDA-approved, it often qualifies for medical insurance coverage, unlike IV ketamine therapy, which is typically self-pay.
Insurance Verification & Cost Review
We contact your insurance provider to confirm eligibility, review coverage, and determine your expected copay or out-of-pocket cost.
Prior Authorization & Copay Assistance
We handle required prior authorization paperwork and help eligible patients explore available Spravato® copay assistance programs.
Out-of-Network & Financing Options
For patients using out-of-network benefits or needing additional payment flexibility, financing options may also be available.
REMS enrollment & medical supervision
As part of the Spravato® treatment regimen, the FDA-required Risk Evaluation and Mitigation Strategy (REMS) is implemented to ensure patient safety and optimal outcomes.
Spravato® is only available through certified treatment centers like Renue Wellness.
It can only be administered in a medical office under direct supervision and is not available for at-home use.
During your initial treatment phase, you may have the opportunity to implement positive life changes to help manage depression symptoms as they respond to treatment.
While ongoing maintenance appointments are often necessary every 4–6 weeks after the initial course, our priority is comprehensive support to help you sustain the results you’ve achieved.
Frequently Asked Questions
About Our Spravato Treatment
Take the first step toward lasting relief
Medically supervised Spravato®, TMS, and IV ketamine therapy — because when nothing else has worked, you deserve care that finally does.
Book a Free Consultation